Home›Erlotinib›Erlotinib + Pantoprazole Sodium In 09 Sodium Chloride

Does Erlotinib Interact with Pantoprazole Sodium In 09 Sodium Chloride?

Erlotinib and Pantoprazole Sodium In 09 Sodium Chloride have a unknown drug interaction according to U.S. FDA drug labeling data. Drugs Dependent on Gastric pH for Absorption (e.g., iron salts, erlotinib, dasatinib, nilotinib, mycophenolate mofetil, ketoconazole/itraconazole) Clinical Impact: Pantoprazole can reduce the absorption of other drugs due to its effect on reducing intragastric acidity. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Unknown
Erlotinib Class
Kinase Inhibitor
Management
Consult your pharmacist
Data Source
U.S. FDA via OpenFDA

What To Tell Your Doctor or Pharmacist

If you are taking Erlotinib and your doctor is considering prescribing Pantoprazole Sodium In 09 Sodium Chloride (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Never stop or change either medication without first consulting your healthcare provider
💊 Erlotinib(Tarceva)+💊 Pantoprazole Sodium In 09 Sodium Chloride(Pantoprazole Sodium)

Severity & Interaction Details

ℹ️
unknown
Interaction documented — severity unclassified
The FDA label notes an interaction but the severity is not classified in our dataset.
Severity scale
MinorContra
On record
Yes
Drug A class
Kinase Inhibitor
Drug B class
—
Source
FDA drug label - pantoprazole sodium in 0.9% sodium chloride

What this means in plain English

Drugs Dependent on Gastric pH for Absorption (e.g., iron salts, erlotinib, dasatinib, nilotinib, mycophenolate mofetil, ketoconazole/itraconazole) Clinical Impact: Pantoprazole can reduce the absorption of other drugs due to its effect on reducing intragastric acidity.

About Erlotinib and Pantoprazole Sodium In 09 Sodium Chloride

Erlotinib is a Kinase Inhibitor. Erlotinib is also sold under the brand name Tarceva. Erlotinib is taken by mouth, whereas Pantoprazole Sodium In 09 Sodium Chloride is given by intravenous (IV) infusion.

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Erlotinib and Pantoprazole Sodium In 09 Sodium Chloride against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.